<DOC>
	<DOCNO>NCT00004375</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate mechanisms ultraviolet A-1 light therapy patient systemic lupus erythematosus normal control .</brief_summary>
	<brief_title>Ultraviolet Light Therapy Systemic Lupus Erythematosus</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Treatment ultraviolet A-1 light administer 5 day week 6 week , low dose frequency require maintain response . The dose frequency progressively decrease next 9 week .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Patients age 15 70 symptomatic systemic lupus erythematosus meeting American Rheumatism Association criterion normal control Prior/Concurrent Therapy No requirement tetracycline photosensitizing drug</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2004</verification_date>
	<keyword>arthritis &amp; connective tissue disease</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>systemic lupus erythematosus</keyword>
</DOC>